The growing payer influence within the pharmaceutical sector has pushed the managed markets function into an increasingly important role. This makes it vital for pharmaceutical organizations to optimize the operations of their managed markets function.
Best Practices, LLC undertook this study to assess the operational performance of managed markets functions within small and mid-cap pharmaceutical companies. The study benchmarks the budget and staffing levels, organizational models, role of clinical specialists, and compensation structure of managed markets functions within pharmaceutical companies. The study will enable managed markets leaders to optimize the performance of their functions while continuing to operate on lean resource levels.